Dicerna Pharmaceuticals Inc - FORM S-1 - EX-23.1 - December 31, 2013

Attached files

file filename
S-1 - FORM S-1 - Dicerna Pharmaceuticals Incd622509ds1.htm
EX-3.1 - EX-3.1 - Dicerna Pharmaceuticals Incd622509dex31.htm
EX-3.2 - EX-3.2 - Dicerna Pharmaceuticals Incd622509dex32.htm
EX-4.4 - EX-4.4 - Dicerna Pharmaceuticals Incd622509dex44.htm
EX-4.5 - EX-4.5 - Dicerna Pharmaceuticals Incd622509dex45.htm
EX-4.3 - EX-4.3 - Dicerna Pharmaceuticals Incd622509dex43.htm
EX-4.6 - EX-4.6 - Dicerna Pharmaceuticals Incd622509dex46.htm
EX-4.2 - EX-4.2 - Dicerna Pharmaceuticals Incd622509dex42.htm
EX-21.1 - EX-21.1 - Dicerna Pharmaceuticals Incd622509dex211.htm
EX-10.7 - EX-10.7 - Dicerna Pharmaceuticals Incd622509dex107.htm
EX-10.4 - EX-10.4 - Dicerna Pharmaceuticals Incd622509dex104.htm
EX-10.5 - EX-10.5 - Dicerna Pharmaceuticals Incd622509dex105.htm
EX-10.2 - EX-10.2 - Dicerna Pharmaceuticals Incd622509dex102.htm
EX-10.6 - EX-10.6 - Dicerna Pharmaceuticals Incd622509dex106.htm
EX-10.1 - EX-10.1 - Dicerna Pharmaceuticals Incd622509dex101.htm
EX-10.3 - EX-10.3 - Dicerna Pharmaceuticals Incd622509dex103.htm
EX-10.20 - EX-10.20 - Dicerna Pharmaceuticals Incd622509dex1020.htm
EX-10.13 - EX-10.13 - Dicerna Pharmaceuticals Incd622509dex1013.htm
EX-10.22 - EX-10.22 - Dicerna Pharmaceuticals Incd622509dex1022.htm
EX-10.16 - EX-10.16 - Dicerna Pharmaceuticals Incd622509dex1016.htm
EX-10.14 - EX-10.14 - Dicerna Pharmaceuticals Incd622509dex1014.htm
EX-10.21 - EX-10.21 - Dicerna Pharmaceuticals Incd622509dex1021.htm
EX-10.11 - EX-10.11 - Dicerna Pharmaceuticals Incd622509dex1011.htm
EX-10.12 - EX-10.12 - Dicerna Pharmaceuticals Incd622509dex1012.htm
EX-10.18 - EX-10.18 - Dicerna Pharmaceuticals Incd622509dex1018.htm
EX-10.15 - EX-10.15 - Dicerna Pharmaceuticals Incd622509dex1015.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated November 8, 2013 relating to the financial statements of Dicerna Pharmaceuticals, Inc. appearing in the Prospectus, which is part of this Registration Statement.

We also consent to the reference to us under the heading “Experts” in such Prospectus.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

December 31, 2013

Dicerna Pharmaceuticals Inc Reports

Also read